SETD3 Methyltransferase Regulates PLK1 Expression to Promote In Situ Hepatic Carcinogenesis

BACKGROUND: The development of a new strategy to overcome chemoresistance to hepatocellular carcinoma (HCC) treatment is a long-standing issue. We have previously found that upregulated SETD3 levels are closely correlated with HCC. This study aims to explore the mechanism underlying how upregulation...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Meng, Yang, Qingmiao, Liu, Yafei, Zhao, Meng-Jie, Du, Xinyuan, Sun, Jiaqi, Shu, Wen-Jie, Huang, Zan, Bi, Jianping, Xu, Ximing, Du, Hai-Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329778/
https://www.ncbi.nlm.nih.gov/pubmed/35912180
http://dx.doi.org/10.3389/fonc.2022.882202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329778/
https://www.ncbi.nlm.nih.gov/pubmed/35912180
http://dx.doi.org/10.3389/fonc.2022.882202

Ejemplares similares